Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinqi Jiangtang
- Development stage
- Unknown
- Lead developer
- Tianjin Pharmaceutical Da Ren Tang Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jinqi Jiangtang is a traditional Chinese medicine formula approved as a Chinese patent medicine for the treatment of type 2 diabetes. It is composed of three herbal ingredients: Coptis chinensis (rhizome), Astragalus membranaceus (root), and Lonicera japonica (flower bud). The formula is based on the classic “Qianjin Huanglian pill” from ancient Chinese medical texts. Its active constituents include alkaloids, polysaccharides, saponins, flavonoids, iridoid glycosides and phenolic acids. Clinical studies have shown that it can lower blood glucose levels and improve insulin sensitivity in patients with type 2 diabetes. Mechanistically, it acts by improving glucose and lipid metabolism and reducing inflammation; some evidence suggests modulation of gut microbiota may also contribute to its effects[1][2][3][5][7][8].
- Brand names
- Jinqi Jiangtang TabletJinQi Jiangtang Capsule
- Other names
- JinQi-JiangTang tabletJinQi Jiangtang tablets金七降糖片 (Chinese)
02
Targets
FGFR1 (Fibroblast growth factor receptor 1)
Beyond the preview
Go deeper on Jinqi Jiangtang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jinqi Jiangtang.